Furthermore, Principe et al. suggested that SMAD4-intact increased T cell infiltration by recruiting more T cells and therefore SMAD4 is an indicator of a survival advantage in patients with pancreatic ductal carcinoma (36). Here, SMAD4 is linked to pancreatic ductal adenocarcinoma.